ClinicalTrials.Veeva

Menu

Machine Learning-based Early Clinical Warning of High-risk Patients

S

Southeast University, China

Status

Enrolling

Conditions

High-risk Patients
Machine Learning
Risk Reduction

Treatments

Device: early warning platform

Study type

Interventional

Funder types

Other

Identifiers

NCT05410171
2021ZDSYLL346-P01

Details and patient eligibility

About

Through the early warning platform for inpatients established by our hospital, the various indicators of patients collected in real time are carried out for automated intelligent evaluation and analysis, early warning of high-risk patients to assess the impact on patient prognosis and the impact on the occurrence of adverse events in inpatients.

Full description

Build the early warning system.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients who use ECG monitoring
  2. Age ≥ 18 years old
  3. Understand and sign an informed consent form

Exclusion criteria

  • Pregnancy or lactation

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

1,000 participants in 2 patient groups

AI group
Experimental group
Description:
patients evaluated by early warning platform
Treatment:
Device: early warning platform
usual care group
No Intervention group
Description:
patients not evaluated by early warning platform

Trial contacts and locations

1

Loading...

Central trial contact

Changde Wu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems